PCN72 Cost Effectiveness Analysis of New Treatments for Metastatic Castration-Resistant Prostate Cancer- Does Severity Matter?
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1189
https://www.valueinhealthjournal.com/article/S1098-3015(12)01254-5/fulltext
Title :
PCN72 Cost Effectiveness Analysis of New Treatments for Metastatic Castration-Resistant Prostate Cancer- Does Severity Matter?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01254-5&doi=10.1016/j.jval.2012.03.1189
First page :
A220
Section Title :
Cancer
Open access? :
No
Section Order :
712